Title: Clinical Efficacy Fuzheng Xiao'ai Decoction Treatment for Esophageal Cancer after Chemotherapy
Abstract: Objective:To observe the clinical efficacy of Fuzheng Xiao'ai decoction(FX) treatment for esophageal cancer after chemotherapy.Method: Seventy-six cases of esophageal cancer after surgery were randomly divided into treatment and control groups.Control group of 37 cases was treated with 5-fluorouracil(5-FU),cisplatin(DDP),and with the necessary symptomatic treatment.On the treatment basis of the control group,the treatment group(n=39) was postoperatively started FX for 12 weeks.The adverse reactions,KPS score,and serum immunoglobulin were observed.Result: The incidences of adverse reactions in treatment group were lower than those in the control group(P0.05,P0.01) including the delayed gastric emptying,diarrhea,loss of appetite and the weight loss 5%.After 1 month of treatment,at the end of chemotherapy and two weeks after the end of chemotherapy,KPS score were higher in the treatment group(P0.01).In the treatment group,IgG,IgA,and IgM levels were higher than those in the controls by the end of the treatment(P0.05,P0.01).However,the total effective rates in the treatment group and the control group were 79.48% and 70.27% accordingly.Conclusion: FX can reduce the adverse reactions caused by esophageal cancer surgery and chemotherapy to improve patients' quality of life,improve immune function.
Publication Year: 2012
Publication Date: 2012-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot